Lv3
220 积分 2024-01-04 加入
Volumetric 68 Ga- prostate-specific membrane antigen PET/computed tomography analysis of bone metastasis subtypes in prostate cancer: correlation with prostate-specific antigen and International Society of Urological Pathology grade
13小时前
求助中
177Lu-PSMA放射性配体疗法治疗前列腺癌安全管理中国专家共识
1个月前
已完结
[Epidemiology of prostate cancer in China: an overview and clinical implication]
3个月前
已完结
Targeted therapy in prostate cancer: beyond PSMA
8个月前
已关闭
177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
9个月前
已完结
Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study
9个月前
已完结
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received177Lu-PSMA-617: Importance of18F-FDG–Avid Discordant Findings
10个月前
已关闭
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre
11个月前
已完结
PO-1473 PSMA PET imaging of non-acinar histological variants of prostate cancer
11个月前
已完结
Developing a novel patient reported outcomes measure for prostate cancer patients receiving radionuclide therapy
11个月前
已完结
皖公网安备34019202002308
